1-5 of 5
Fahmida Hoq
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Donor-Derived Tumor Associated Antigen-Specific T Cell Therapy in Patients with High-Risk or Relapsed Acute Leukemia Post Allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, Conrad Russell Young Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kirsten M. Williams, Hema Dave, Jeffrey Dome, David Jacobsohn, Patrick Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood
Blood (2021) 138 (Supplement 1): 2828.
https://doi.org/10.1182/blood-2021-153207
Published: 2021
Journal Articles

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Michael D. Keller, Katherine M. Harris, Mariah A. Jensen-Wachspress, Vaishnavi V. Kankate, Haili Lang, Christopher A. Lazarski, Jessica Durkee-Shock, Ping-Hsien Lee, Kajal Chaudhry, Kathleen Webber, Anushree Datar, Madeline Terpilowski, Emily K. Reynolds, Eva M. Stevenson, Stephanie Val, Zoe Shancer, Nan Zhang, Robert Ulrey, Uduak Ekanem, Maja Stanojevic, Ashley Geiger, Hua Liang, Fahmida Hoq, Allistair A. Abraham, Patrick J. Hanley, C. Russell Cruz, Kathleen Ferrer, Lesia Dropulic, Krista Gangler, Peter D. Burbelo, R. Brad Jones, Jeffrey I. Cohen, Catherine M. Bollard
Journal: Blood
Blood (2020) 136 (25): 2905–2917.
https://doi.org/10.1182/blood.2020008488
Published: 2020
Includes: Supplemental data
Journal Articles

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Clinical Trials & Observations
Lauren P. McLaughlin, Rayne Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng-Fen Wu, Fahmida Hoq, Bambi Grilley, Andrea M. Marcogliese, Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard
Journal: Blood
Blood (2018) 132 (22): 2351–2361.
https://doi.org/10.1182/blood-2018-07-863654
Published: 2018
Journal Articles

Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors

Patrick Hanley, PhD, Michael Keller, MD, Lauren Roesch, Devin Saunders, Haili Lang, Blachy Davila, MD, Ulrich A. Duffner, MD, Divyesh Kukadiya, Fahmida Hoq, MD, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4470.
https://doi.org/10.1182/blood.V130.Suppl_1.4470.4470
Published: 2017
Journal Articles

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Kirsten M. Williams, MD, Patrick Hanley, PhD, Melanie Grant, PhD, Maria Fernanda Fortiz, BA, Maja Stanojevic, MD, Mimi Ismail, BA, Fahmida Hoq, MD, Maria Martin Manso, PhD, Jamie Hoover, Robert Ulrey, BA, Ella Kathy Mintz, MS, Anna Namata, BS, Elizabeth Williams, Shuroug Albihani, Michael Keller, MD, Conrad Russell Young Cruz, MD PhD, Haili Lang, Austin John Barrett, MD FRCP, FRCPath, Stephen Gottschalk, MD, Hao Liu, Shannon R. McCurdy, MD, Richard J. Jones, MD, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4516.
https://doi.org/10.1182/blood.V130.Suppl_1.4516.4516
Published: 2017